Sam Collaudin, PhD, jMBA

Dr. Sam Collaudin is an independent consultant in business analysis and strategy for biotech companies developing drugs and devices in diabetes and related diseases. He specialized in helping new projects to adapt to the needs of patients and to be integrated into the complex diabetes ecosystem. With training between mathematics and biology, he has a strong interest in the development of artificial pancreas and the interactions between devices and drugs. He realizes a quarterly summary of R&D in diabetes at the destination of clinicians, HCPs and companies. Sam was previously a business analyst at Adocia, he has a PhD in biology and bio-mathematics and a jMBA in biotech management. He lives between France and Germany. You can follow him on Linkedin: https://www.linkedin.com/in/sam-collaudin-01313968/